Viewing Study NCT07288203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-02-20 @ 6:21 PM
Study NCT ID: NCT07288203
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Sponsor: Iovance Biotherapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin Cancer) View
None Unresectable Melanoma View
None Metastatic Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tumor Infiltrating Lymphocytes View
None TIL View
None Metastatic Melanoma View
None Unresectable Melanoma View
None Cell Therapy View
None Cellular Immuno-therapy View
None IL-2 View
None Non-myeloablative lymphodepletion (NMALD) View
None Melanoma View
None Lifileucel View
None Skin Cancer View
None LN-144 View
None BRAF v600 View
None BRAF/MEK View